FDA
approval
· 2015-09-30
FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)
Summary
FDA approved a supplemental application for OVIDREL (choriogonadotropin alfa) submitted by EMD Serono, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OVIDREL (CHORIOGONADOTROPIN ALFA)